South Korea · Delayed Price · Currency is KRW Kookjeon Pharmaceutical Statistics
Total Valuation
KOSDAQ:307750 has a market cap or net worth of KRW 118.50 billion. The enterprise value is 127.24 billion.
| Market Cap | 118.50B |
| Enterprise Value | 127.24B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:307750 has 53.99 million shares outstanding. The number of shares has increased by 1.15% in one year.
| Current Share Class | 53.99M |
| Shares Outstanding | 53.99M |
| Shares Change (YoY) | +1.15% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 52.24% |
| Owned by Institutions (%) | 0.17% |
| Float | 25.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | 11.09 |
| P/OCF Ratio | 8.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.64, with an EV/FCF ratio of 11.91.
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | 16.64 |
| EV / EBIT | 54.19 |
| EV / FCF | 11.91 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.47 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 5.37 |
| Debt / FCF | 3.80 |
| Interest Coverage | 0.53 |
Financial Efficiency
Return on equity (ROE) is -1.94% and return on invested capital (ROIC) is -0.01%.
| Return on Equity (ROE) | -1.94% |
| Return on Assets (ROA) | 0.73% |
| Return on Invested Capital (ROIC) | -0.01% |
| Return on Capital Employed (ROCE) | 1.74% |
| Weighted Average Cost of Capital (WACC) | 4.14% |
| Revenue Per Employee | 756.02M |
| Profits Per Employee | -10.38M |
| Employee Count | 178 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 4.81 |
Taxes
| Income Tax | -441.53M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.57% in the last 52 weeks. The beta is -0.28, so KOSDAQ:307750's price volatility has been lower than the market average.
| Beta (5Y) | -0.28 |
| 52-Week Price Change | -44.57% |
| 50-Day Moving Average | 2,189.76 |
| 200-Day Moving Average | 3,245.19 |
| Relative Strength Index (RSI) | 50.26 |
| Average Volume (20 Days) | 109,629 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:307750 had revenue of KRW 134.57 billion and -1.85 billion in losses. Loss per share was -36.19.
| Revenue | 134.57B |
| Gross Profit | 20.80B |
| Operating Income | 2.27B |
| Pretax Income | -2.53B |
| Net Income | -1.85B |
| EBITDA | 7.57B |
| EBIT | 2.27B |
| Loss Per Share | -36.19 |
Balance Sheet
The company has 33.15 billion in cash and 40.64 billion in debt, with a net cash position of -7.48 billion or -138.59 per share.
| Cash & Cash Equivalents | 33.15B |
| Total Debt | 40.64B |
| Net Cash | -7.48B |
| Net Cash Per Share | -138.59 |
| Equity (Book Value) | 114.00B |
| Book Value Per Share | 2,085.30 |
| Working Capital | 27.42B |
Cash Flow
In the last 12 months, operating cash flow was 13.75 billion and capital expenditures -3.06 billion, giving a free cash flow of 10.69 billion.
| Operating Cash Flow | 13.75B |
| Capital Expenditures | -3.06B |
| Depreciation & Amortization | 5.25B |
| Net Borrowing | -14.07B |
| Free Cash Flow | 10.69B |
| FCF Per Share | 197.96 |
Margins
Gross margin is 15.45%, with operating and profit margins of 1.69% and -1.37%.
| Gross Margin | 15.45% |
| Operating Margin | 1.69% |
| Pretax Margin | -1.88% |
| Profit Margin | -1.37% |
| EBITDA Margin | 5.63% |
| EBIT Margin | 1.69% |
| FCF Margin | 8.39% |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 0.47%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 0.47% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.15% |
| Shareholder Yield | -0.68% |
| Earnings Yield | -1.56% |
| FCF Yield | 9.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:307750 has an Altman Z-Score of 2.61 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.61 |
| Piotroski F-Score | 7 |